Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappab signaling pathway in human osteoblasts

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages 189-194

  Ning, Rende ^a,b   Zhang, Xianlong ^a   Guo, Xiaokui ^c   Li, Qingtian ^c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemokine CCL2; Interleukin 6; NF kappaB; Osteoblasts; Staphylococcus aureus

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NONHUMAN; OSTEOBLAST; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; SUPERNATANT;

EID: 79959604279     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70173-8     Document Type: Article

References (38)

1. Jorge LS, Chueire AG, Rossit ARB. Osteomyelitis: a current challenge. Braz J Infect Dis 2010; 14:310-5.
2. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364:369-79.
3. Bost KL, Ramp WK, Nicholson NC et al. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis 1999; 180:1912-20.
4. Bost KL, Bento JL, Petty CC et al. Monocyte chemoattractant protein-1 expression by osteoblasts following infection with Staphylococcus aureus or Salmonella. J Interferon Cytokine Res 2001; 21:297-304.
5. Marriott I. Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression. Immunol Res 2004; 30:291-308.
6. Wright KM, Friedland JS. Regulation of chemokine gene expression and secretion in Staphylococcus aureus-infected osteoblasts. Microbes Infect 2004; 6:844-52.
7. Naumann M, Wessler S, Bartsch C et al. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of infammatory cytokines. J Exp Med 1997; 186:247-58.
8. Carmody RJ, Chen YH. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4:31-41.
9. Kriete A, Mayo KL. Atypical pathways of NF-kappaB activation and aging. Exp Gerontol 2009; 44:250-5.
10. Morotti A, Cilloni D, Pautasso M et al. NF-κB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line. Am J Hematol 2006; 81:938-45.
11. Panzer U, Steinmetz OM, Turner JE et al. Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol 2009; 297:F429-39.
12. Ohno T, Okahashi N, Morisaki I, Amano A. Signaling pathways in osteoblast proinflammatory responses to infection by Porphyromonas gingivalis. Oral Microbiol Immunol 2008; 23:96-104.
13. Tsai PJ, Chen YH, Hsueh CH et al. Streptococcus pyogenes induces epithelial inflammatory responses through NF-kappaB/MAPK signaling pathways. Microbes Infect 2006; 8:1440-9.
14. Medina E, Anders D, Chhatwal GS. Induction of NF-kappaB nuclear translocation in human respiratory epithelial cells by group A streptococci. Microb Pathog 2002; 33:307-13.
15. Mendez-Samperio P, Perez A, Rivera L. Mycobacterium bovis Bacillus Calmette-Guerin (BCG)-induced activation of PI3K/Akt and NF-κB signaling pathways regulates expression of CXCL10 in epithelial cells. Cell Immunol 2009; 256:12-8.
16. Nishimoto N, Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004; 4:386-91.
17. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8:253-78.
18. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299:1033-6.
19. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29:313-26.
20. Sakamoto A, Ishibashi-Ueda H, Sugamoto Y et al. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. Clin Sci (Lond) 2008; 114:643-50.
21. Marriott I, Gray DL, Tranguch SL et al. Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Am J Pathol 2004; 164:1399-406.
22. Marriott I, Gray DL, Rati DM et al. Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone 2005; 37:504-12.
23. Somayaji SN, Ritchie S, Sahraei M et al. Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun 2008; 76:5120-6.
24. Zhu J, Zhang X, Wang C, Peng X. Periprosthetic strain magnitude-dependent upregulation of type I collagen synthesis in human osteoblasts through an ERK1/2 pathway. Int Orthop 2009; 33:1455-60.
25. Andela VB, Rosier RN. The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids. Mol Cancer 2004; 3:8.
26. Fantuzzi L, Spadaro F, Purificato C et al. Phosphatidylcholinespecific phospholipase Cactivation is required for CCR5-dependent, NF-κB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. Blood 2008; 111:3355-63.
27. Mitchell D, Olive C. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogenactivated protein kinases. Mol Immunol 2010; 47:2065-73.
28. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
29. Bekeredjian-Ding I, Inamura S, Giese T et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol 2007; 178:2803-12.
30. Dessing MC, Schouten M, Draing C et al. Role played by Tolllike receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. J Infect Dis 2008; 197:245-52.
31. Miyake K. Innate recognition of lipopolysaccharide by Tolllike receptor 4-MD-2. Trends Microbiol 2004; 12:186-92.
32. Takeuchi O, Akira S. MyD88 as a bottle neck in Toll/IL-1 signaling. Curr Top Microbiol Immunol 2002; 270:155-67.
33. Kikuchi T, Matsuguchi T, Tsuboi N et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001; 166:3574-9.
34. Varoga D, Wruck CJ, Tohidnezhad M et al. Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. Histochem Cell Biol 2009; 131:207-18.
35. Gasper NA, Petty CC, Schrum LW et al. Bacterium-induced CXCL10 secretion by osteoblasts can be mediated in part through toll-like receptor 4. Infect Immun 2002; 70:4075-82.
36. Madrazo DR, Tranguch SL, Marriott I. Signaling via Toll-like receptor 5 can initiate inflammatory mediator production by murine osteoblasts. Infect Immun 2003; 71:5418-21.
37. Zou W, Amcheslavsky A, Bar-Shavit Z. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J Biol Chem 2003; 278:16732-40.
38. Liou HC. Regulation of the immune system by NF-kappaB and IkappaB. J Biochem Mol Biol 2002; 35:537-46.